ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
2L9,BLUEPRINT MEDICINES CORP,09627Y109,91311000.0,3255280,18.345672811291376,2017-02-14,2016-12-31,0000921895-17-000368
CYTK,CYTOKINETICS INC,23282W605,58948000.0,4851691,11.843487869807625,2017-02-14,2016-12-31,0000921895-17-000368
CCXIEUR,CHEMOCENTRYX INC,16383L106,57709000.0,7798572,11.594555226279573,2017-02-14,2016-12-31,0000921895-17-000368
ARRYEUR,ARRAY BIOPHARMA INC,04269X105,43829000.0,4986186,8.80586669345522,2017-02-14,2016-12-31,0000921895-17-000368
CNCEEUR,CONCERT PHARMACEUTICALS INC,206022105,26921000.0,2616249,5.408810085890803,2017-02-14,2016-12-31,0000921895-17-000368
XENE,XENON PHARMACEUTICALS INC,98420N105,23437000.0,3043805,4.70882515445276,2017-02-14,2016-12-31,0000921895-17-000368
N/A,FORWARD PHARMA A/S,34986J105,20832000.0,1387853,4.1854437691496305,2017-02-14,2016-12-31,0000921895-17-000368
N/A,CTI BIOPHARMA CORP,12648L106,18053000.0,44796940,3.627103320106485,2017-02-14,2016-12-31,0000921895-17-000368
N/A,COLUCID PHARMACEUTICALS INC,19716T101,17630000.0,484335,3.5421166306695464,2017-02-14,2016-12-31,0000921895-17-000368
N/A,GLYCOMIMETICS INC,38000Q102,17240000.0,2826282,3.463760108493646,2017-02-14,2016-12-31,0000921895-17-000368
N/A,ONCOMED PHARMACEUTICALS INC,68234X102,13573000.0,1760489,2.727007885880757,2017-02-14,2016-12-31,0000921895-17-000368
N/A,CASCADIAN THERAPEUTICS INC,14740B606,13504000.0,3133224,2.7131448088804055,2017-02-14,2016-12-31,0000921895-17-000368
INFIQ,INFINITY PHARMACEUTICALS INC,45665G303,10612000.0,7860808,2.1321010598221912,2017-02-14,2016-12-31,0000921895-17-000368
ACHNEUR,ACHILLION PHARMACEUTICALS INC COM,00448Q201,10008000.0,2423300,2.010748907529258,2017-02-14,2016-12-31,0000921895-17-000368
FATE,FATE THERAPEUTICS INC,31189P102,9436000.0,3759398,1.8958260083379377,2017-02-14,2016-12-31,0000921895-17-000368
ARQLUSD,ARQULE INC,04269E107,9324000.0,7400128,1.8733236224822944,2017-02-14,2016-12-31,0000921895-17-000368
ESPR,ESPERION THERAPEUTICS INC NE,29664W105,8924000.0,712770,1.79295795871214,2017-02-14,2016-12-31,0000921895-17-000368
ADROEUR,ADURO BIOTECH INC,00739L101,8503000.0,745886,1.7083730975940528,2017-02-14,2016-12-31,0000921895-17-000368
N/A,IMMUNE DESIGN CORP,45252L103,7261000.0,1320164,1.4588377115877242,2017-02-14,2016-12-31,0000921895-17-000368
CTMX,CYTOMX THERAPEUTICS INC,23284F105,6097000.0,554806,1.2249736300165754,2017-02-14,2016-12-31,0000921895-17-000368
N/A,GTX INC DEL,40052B207,5853000.0,1108433,1.1759505751167814,2017-02-14,2016-12-31,0000921895-17-000368
SNSSEUR,SUNESIS PHARMACEUTICALS INC,867328700,5042000.0,1392720,1.0130091918227937,2017-02-14,2016-12-31,0000921895-17-000368
N/A,NIVALIS THERAPEUTICS INC,65481J109,4176000.0,1864474,0.8390175297604099,2017-02-14,2016-12-31,0000921895-17-000368
OREXQ 2.75 12/01/20,OREXIGEN THERAPEUTICS INC,686164AB0,3000000.0,10000000,0.6027424782761565,2017-02-14,2016-12-31,0000921895-17-000368
N/A,PIERIS PHARMACEUTICALS INC,720795103,2606000.0,1854768,0.5235822994625546,2017-02-14,2016-12-31,0000921895-17-000368
N/A,PAIN THERAPEUTICS INC,69562K100,1299000.0,2278552,0.2609874930935758,2017-02-14,2016-12-31,0000921895-17-000368
N/A,OREXIGEN THERAPEUTICS INC,686164302,1279000.0,734976,0.25696920990506805,2017-02-14,2016-12-31,0000921895-17-000368
XOMA,XOMA CORP DEL,98419J206,1278000.0,302800,0.25676829574564264,2017-02-14,2016-12-31,0000921895-17-000368
N/A,ANTHERA PHARMACEUTICALS INC,03674U201,40000.0,62292,0.00803656637701542,2017-02-14,2016-12-31,0000921895-17-000368
